The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引:84
作者
Khezri, Mohammad Rafi [1 ]
Jafari, Reza [2 ]
Yousefi, Keyvan [3 ]
Zolbanin, Naime Majidi [4 ,5 ,6 ]
机构
[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran
[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA
[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran
[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran
[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran
关键词
Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;
D O I
10.1016/j.yexmp.2022.104787
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.
引用
收藏
页数:12
相关论文
共 200 条
[1]   PI3K/Akt-mediated regulation of p53 in cancer [J].
Abraham, Aswin G. ;
O'Neill, Eric .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 :798-803
[2]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[3]   PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis [J].
Alqahtani, Ali ;
Ayesh, Hazem S. K. ;
Halawani, Hafez .
CANCERS, 2020, 12 (01)
[4]  
Ataie-Kachoie P, 2015, AM J CANCER RES, V5, P575
[5]   AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization [J].
Azzalini, Eros ;
Tierno, Domenico ;
Bartoletti, Michele ;
Barbazza, Renzo ;
Giorda, Giorgio ;
Puglisi, Fabio ;
Cecere, Sabrina Chiara ;
Losito, Nunzia Simona ;
Russo, Daniela ;
Stanta, Giorgio ;
Canzonieri, Vincenzo ;
Bonin, Serena .
CANCERS, 2022, 14 (02)
[6]   Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma [J].
Babae, Negar ;
Bourajjaj, Meriem ;
Liu, Yijia ;
Van Beijnum, Judy R. ;
Cerisoli, Francesco ;
Scaria, Puthupparampil V. ;
Verheul, Mark ;
Van Berkel, Maaike P. ;
Pieters, Ebel H. E. ;
Van Haastert, Rick J. ;
Yousefi, Afrouz ;
Mastrobattista, Enrico ;
Storm, Gert ;
Berezikov, Eugene ;
Cuppen, Edwin ;
Woodle, Martin ;
Schaapveld, Roel Q. J. ;
Prevost, Gregoire P. ;
Griffioen, Arjan W. ;
Van Noort, Paula I. ;
Schiffelers, Raymond M. .
ONCOTARGET, 2014, 5 (16) :6687-6700
[7]   Akt Isoforms: A Family Affair in Breast Cancer [J].
Basu, Alakananda ;
Lambring, Christoffer Briggs .
CANCERS, 2021, 13 (14)
[8]  
Biaglow JE, 2005, CANCER BIOL THER, V4, P6
[9]   Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator [J].
Bin Hafeez, Bilal ;
Adhami, Vaqar Mustafa ;
Asim, Mohammad ;
Siddiqui, Imtiaz A. ;
Bhat, Kumar M. ;
Zhong, Weixiong ;
Saleem, Mohammad ;
Din, Maria ;
Setaluri, Vijayasaradhi ;
Mukhtar, Hasan .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :452-459
[10]   PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement [J].
Bonin, S. ;
Pracella, D. ;
Barbazza, R. ;
Dotti, I. ;
Boffo, S. ;
Stanta, G. .
DISEASE MARKERS, 2019, 2019